Qifeng Ji

509 total citations
16 papers, 384 citations indexed

About

Qifeng Ji is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Qifeng Ji has authored 16 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Oncology. Recurrent topics in Qifeng Ji's work include Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Immune cells in cancer (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Qifeng Ji is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Immune cells in cancer (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Qifeng Ji collaborates with scholars based in China. Qifeng Ji's co-authors include Siyuan Zhou, Miao Liu, Bang‐Le Zhang, Daozhou Liu, Qibing Mei, Ying Cheng, Ying Cheng, Bao Liu, Meng‐Lei Huan and Fangyuan Li and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and Small.

In The Last Decade

Qifeng Ji

16 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qifeng Ji China 11 188 124 86 61 56 16 384
Yihui Bi China 11 164 0.9× 123 1.0× 39 0.5× 34 0.6× 114 2.0× 21 463
Safwan Alomari United States 10 174 0.9× 191 1.5× 138 1.6× 30 0.5× 37 0.7× 22 557
Xiangjun Tang China 15 309 1.6× 97 0.8× 75 0.9× 46 0.8× 89 1.6× 28 552
Shahram Torkamandi Iran 9 233 1.2× 58 0.5× 40 0.5× 24 0.4× 58 1.0× 21 459
Jinning Mao China 11 138 0.7× 211 1.7× 135 1.6× 24 0.4× 35 0.6× 21 470
Junjie Yuan China 14 217 1.2× 125 1.0× 29 0.3× 31 0.5× 39 0.7× 36 483
Jin He China 15 232 1.2× 116 0.9× 125 1.5× 52 0.9× 32 0.6× 36 598
Kun Fan China 10 184 1.0× 58 0.5× 59 0.7× 47 0.8× 39 0.7× 16 391
Claire M.F. Potter United Kingdom 12 264 1.4× 78 0.6× 63 0.7× 71 1.2× 83 1.5× 14 640

Countries citing papers authored by Qifeng Ji

Since Specialization
Citations

This map shows the geographic impact of Qifeng Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qifeng Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qifeng Ji more than expected).

Fields of papers citing papers by Qifeng Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qifeng Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qifeng Ji. The network helps show where Qifeng Ji may publish in the future.

Co-authorship network of co-authors of Qifeng Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Qifeng Ji. A scholar is included among the top collaborators of Qifeng Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qifeng Ji. Qifeng Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Zhang, Luoqi, Miao Liu, Qifeng Ji, et al.. (2025). Hybrid membrane-coated Cyclosporine A nanocrystals preventing secondary brain injury via alleviating neuroinflammatory and oxidative stress. Journal of Controlled Release. 383. 113795–113795. 1 indexed citations
2.
Sun, Yang, Miao Liu, Ying Cheng, et al.. (2025). Automatic target-seeking nanoparticle inhibiting orthotopic drug-resistant colon cancer and liver metastases via regulating cancer cell adhesion and proliferation. Journal of Nanobiotechnology. 23(1). 423–423. 1 indexed citations
3.
Cheng, Ying, Zhifu Yang, Qifeng Ji, et al.. (2024). Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction. Journal of Nanobiotechnology. 22(1). 93–93. 12 indexed citations
4.
Liu, Daozhou, Miao Liu, Qifeng Ji, et al.. (2024). The Mitochondria‐Targeted Micelle Inhibits Alzheimer's Disease Progression by Alleviating Neuronal Mitochondrial Dysfunction and Neuroinflammation. Small. 21(6). e2408581–e2408581. 10 indexed citations
5.
Liu, Daozhou, Ying Han, Miao Liu, et al.. (2023). Cyclosporine A-loaded apoferritin alleviates myocardial ischemia-reperfusion injury by simultaneously blocking ferroptosis and apoptosis of cardiomyocytes. Acta Biomaterialia. 160. 265–280. 34 indexed citations
6.
Han, Ying, Daozhou Liu, Ying Cheng, et al.. (2023). Maintenance of mitochondrial homeostasis for Alzheimer's disease: Strategies and challenges. Redox Biology. 63. 102734–102734. 26 indexed citations
7.
8.
Li, Fangyuan, Daozhou Liu, Miao Liu, et al.. (2022). Tregs biomimetic nanoparticle to reprogram inflammatory and redox microenvironment in infarct tissue to treat myocardial ischemia reperfusion injury in mice. Journal of Nanobiotechnology. 20(1). 251–251. 37 indexed citations
9.
Liu, Daozhou, Qifeng Ji, Ying Cheng, et al.. (2022). Cyclosporine A loaded brain targeting nanoparticle to treat cerebral ischemia/reperfusion injury in mice. Journal of Nanobiotechnology. 20(1). 256–256. 39 indexed citations
10.
Liu, Bao, Qifeng Ji, Ying Cheng, et al.. (2022). Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. Journal of Nanobiotechnology. 20(1). 161–161. 51 indexed citations
11.
Liu, Daozhou, Ying Cheng, Miao Liu, et al.. (2022). Nano-Codelivery of Temozolomide and siPD-L1 to Reprogram the Drug-Resistant and Immunosuppressive Microenvironment in Orthotopic Glioblastoma. ACS Nano. 16(5). 7409–7427. 45 indexed citations
12.
Cheng, Ying, Miao Liu, Qifeng Ji, et al.. (2021). Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme. Journal of Controlled Release. 336. 54–70. 56 indexed citations
13.
Sun, Yang, Ying Cheng, Weiliang Ye, et al.. (2021). MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer. Journal of Nanobiotechnology. 19(1). 367–367. 18 indexed citations
14.
Yang, Qian, Daozhou Liu, Miao Liu, et al.. (2020). Bone-Targeted Calcium Phosphate-Polymer Hybrid Nanoparticle Co-Deliver Zoledronate and Docetaxel to Treat Bone Metastasis of Prostate Cancer. Journal of Pharmaceutical Sciences. 110(2). 876–887. 16 indexed citations
15.
16.
Cheng, Ying, Qifeng Ji, Miao Liu, et al.. (2020). Bone-Targeted PAMAM Nanoparticle to Treat Bone Metastases of Lung Cancer. Nanomedicine. 15(9). 833–849. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yihui Bi Breakdown of academic impact, for papers by Safwan Alomari Breakdown of academic impact, for papers by Xiangjun Tang Breakdown of academic impact, for papers by Shahram Torkamandi Breakdown of academic impact, for papers by Jinning Mao Breakdown of academic impact, for papers by Junjie Yuan Breakdown of academic impact, for papers by Jin He Breakdown of academic impact, for papers by Kun Fan Breakdown of academic impact, for papers by Claire M.F. Potter
Rankless by CCL
2026